Elbit Med Tech Stock Net Income
EMTC Stock | ILS 15.30 0.30 1.92% |
Elbit Med Tech fundamentals help investors to digest information that contributes to Elbit Med's financial success or failures. It also enables traders to predict the movement of Elbit Stock. The fundamental analysis module provides a way to measure Elbit Med's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Elbit Med stock.
Elbit |
Elbit Med Tech Company Net Income Analysis
Elbit Med's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Elbit Med Net Income | (15.52 M) |
Most of Elbit Med's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Elbit Med Tech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition |
Based on the recorded statements, Elbit Med Tech reported net income of (15.52 Million). This is 104.55% lower than that of the Health Care Equipment & Supplies sector and 106.52% lower than that of the Health Care industry. The net income for all Israel stocks is 102.72% higher than that of the company.
Did you try this?
Run Fundamentals Comparison Now
Fundamentals ComparisonCompare fundamentals across multiple equities to find investing opportunities |
All Next | Launch Module |
Elbit Fundamentals
Return On Equity | 0.0237 | |||
Return On Asset | -0.0038 | |||
Profit Margin | 0.51 % | |||
Operating Margin | (0.25) % | |||
Current Valuation | 46.83 M | |||
Shares Outstanding | 92.79 M | |||
Shares Owned By Insiders | 84.51 % | |||
Price To Book | 0.63 X | |||
Price To Sales | 0.71 X | |||
Gross Profit | 135.14 M | |||
EBITDA | (13.26 M) | |||
Net Income | (15.52 M) | |||
Cash And Equivalents | 1.36 M | |||
Current Ratio | 4.07 X | |||
Book Value Per Share | 0.48 X | |||
Cash Flow From Operations | (547 K) | |||
Earnings Per Share | 0.01 X | |||
Number Of Employees | 472 | |||
Beta | 0.29 | |||
Market Capitalization | 1.36 M | |||
Total Asset | 31.1 M | |||
Working Capital | 4 M | |||
Current Asset | 4 M | |||
Net Asset | 31.1 M |
About Elbit Med Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Elbit Med Tech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Elbit Med using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Elbit Med Tech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Elbit Med
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Elbit Med position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elbit Med will appreciate offsetting losses from the drop in the long position's value.Moving together with Elbit Stock
0.91 | BOLT | BioLight Life Sciences | PairCorr |
Moving against Elbit Stock
0.86 | PSTI | Pluristem | PairCorr |
0.65 | GPGB | GP Global Power | PairCorr |
0.6 | PRTC | Priortech | PairCorr |
0.57 | AQUA | Aquarius Engines | PairCorr |
0.5 | APLP | Apollo Power | PairCorr |
The ability to find closely correlated positions to Elbit Med could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Elbit Med when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Elbit Med - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Elbit Med Tech to buy it.
The correlation of Elbit Med is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Elbit Med moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Elbit Med Tech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Elbit Med can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Elbit Med Tech. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Complementary Tools for Elbit Stock analysis
When running Elbit Med's price analysis, check to measure Elbit Med's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elbit Med is operating at the current time. Most of Elbit Med's value examination focuses on studying past and present price action to predict the probability of Elbit Med's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elbit Med's price. Additionally, you may evaluate how the addition of Elbit Med to your portfolios can decrease your overall portfolio volatility.
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |